Patents by Inventor Michael Bettan

Michael Bettan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System for regulating in vivo the expression of a transgene by conditional inhibition
    Publication number: 20050289658
    Abstract: The present invention relates to novel constructs and compositions and to a novel method for regulating the expression of a transgene of interest in vivo by conditional inhibition, and to the uses thereof in experimental, clinical and therapeutic domains or for the production of animals or plants. For example, the novel regulation method is based on the coexpression of a transgene of interest encoding a transcript of interest and of an inhibitory transgene encoding an inhibitory transcript specific for the transcript of interest, so as to obtain constitutive inhibition of the activity of the transcript of interest, and to be able to ensure effective regulation of the transcript of interest, either by inhibiting its inhibitory transcript, or by activating the transcript of interest, or alternatively by activating the transcript of interest and concomitantly inhibiting its inhibitory transcript.
    Type: Application
    Filed: April 15, 2005
    Publication date: December 29, 2005
    Inventors: Daniel Scherman, Michael Bettan, Pascal Bigey
  • System for regulating in vivo the expression of a transgene by conditional inhibition
    Publication number: 20020166132
    Abstract: The present invention relates to novel constructs and compositions and to a novel method for regulating the expression of a transgene of interest in vivo by conditional inhibition, and to the uses thereof in experimental, clinical and therapeutic domains or for the production of animals or plants.
    Type: Application
    Filed: August 17, 2001
    Publication date: November 7, 2002
    Inventors: Daniel Scherman, Michael Bettan, Pascal Bigey
  • In-situ-generated solid radiation source based on Tungsten 188 /Rhenium 188 and use thereof
    Patent number: 6409943
    Abstract: A radiotheraputical source of Rhenium188 comprises metallic Tungsten188 or a metal oxide of Tungsten188. Therapeutic device using Rhenium188 comprise a radioactive source for the in situ generation of Rhenium188 from Tungsten188.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: June 25, 2002
    Assignee: The State of Israel, Atomic Energy Commission
    Inventors: Efraim Lavie, Daniel Kijel, Eliahu Sayag, Yehoshua Michael Bettan